Completed PHASE3 INTERVENTIONAL 4-arm NCT00384189

A Comparative Study of Inhaled Ciclesonide Versus Placebo in Children (6-11 Years) With Asthma (RAINBOW)

A Comparative Study of Inhaled Ciclesonide Versus Placebo in Children With Asthma

Sponsor: AstraZeneca

Conditions Asthma

Interventions Ciclesonide Placebo Salbutamol

Updated 7 times since 2017 Last updated: Dec 2, 2016 Started: Sep 30, 2006 Primary completion: Aug 31, 2007 Completion: Aug 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Asthma and is currently completed. AstraZeneca leads this study, which shows 7 recorded versions since 2006 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed PHASE3
Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Sep 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

AstraZeneca
Nycomed GmbH

Data source: AstraZeneca

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Barcelona, Spain , Bellville - Cape Town -, South Africa , Bloemfontein, South Africa , Brasov, Romania , Bucharest, Romania , Budapest, Hungary , Cape Town, South Africa , Centurion, South Africa , Chelyabinsk, Russia , Cluj-Napoca, Romania and 75 more locations